Nanotechnology in Medicine – Thematic Research

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Nanotechnology in Medicine Report Overview

A persistent problem in medicine is the lack of ability to specifically target diseased cells and tissues. Drugs are often administered as free compounds. This non-specific mode of delivery relies on the drug molecules to serendipitously reach target cells. Nanomedicine refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the ability to target specific cells or tissues. These materials are produced on a nanoscale level and are safe to introduce into the body. Applications for nanotechnology in medicine include imaging, diagnosis, or the delivery of drugs that will help medical professionals treat various diseases.

The nanotechnology in medicine research report will focus on nanotechnology and nanomedicines that are currently approved by the FDA. Specifically, the nanotechnology that will be covered includes liposomes, microbubbles, and nanoparticles. All these technologies are approved either on their own or in combination with specific drugs.

Key trends Technology Trends, Macroeconomic Trends, and Regulatory Trends
Key value chains Imaging, Diagnostics, and Therapy
Leading public companies Amgen, Bausch Health Companies, Biogen, Celgene, Eisai, F. Hoffmann-La Roche, Gilead Sciences, Ipsen, Jazz Pharmaceuticals, Lantheus Holdings, Merck, and Novo Nordisk
Leading private companies AlfaSigma, Dompe Farmaceutici, GE Healthcare, Horizon Pharmaceuticals, and Janssen Pharmaceuticals

Trends That Will Impact the Nanotechnology in Medicine Theme

The key trends that will impact the nanotechnology in medicine theme in the coming months can be divided into three categories: technology trends, macroeconomic trends, and regulatory trends.

Technology trends

The main technology trends that will impact the nanotechnology in medicine theme are target specification, controlled drug release, and understanding different patient populations.

Macroeconomic trends

The main macroeconomic trends that will impact the nanotechnology in medicine theme are clinical trials, lack of nanomaterial experts, mergers & acquisitions, and nanomedicine production.

Regulatory trends

The main regulatory trends that will impact the nanotechnology in medicine theme are FDA regulation of nanotechnology, government & regulatory agencies, and patents & IP.

Nanotechnology in Medicine Value Chains Analysis

The key nanotechnology in medicine value chains can be divided into three segments: imaging, diagnostics, and therapy.


Microbubbles are approved by the FDA as imaging contrast agents. They can be injected intravenously into patients and enhance imaging techniques, such as ultrasound by vibrating upon stimulation by energy. Currently, the market is dominated by three companies: Lantheus Holdings, Dompe Farmaceutici, and GE Healthcare, which manufacture the FDA-approved products Definity, Lumason, and Optison, respectively.


While not yet clinically approved, liposomes have been studied for the diagnosis of various diseases. For example, PEGylated liposomes have been demonstrated to be useful for the diagnosis of obstructed coronary arteries that can lead to ischemic myocardium. In addition, liposomes encapsulating fluorescent dye have been used for the diagnosis of cerebral malaria and inflammation. Finally, liposomes have been proven to be useful for the diagnosis of various tumors upon update by various types of cancer cells, including breast cancer cells. Once the liposomes interact with the tumors, signals are generated by pH changes and can be detected by clinicians.


Nanotechnology in medicine is predominantly used for therapeutic purposes. Currently, there are over 25 different nanomedicines approved by the FDA for indications such as oncology, pain relief, macular degeneration, Crohn’s disease, multiple sclerosis, and hemophilia. These nanomedicines use liposomes and other nanoparticle-drug conjugates to deliver, increase the efficiency of uptake by tissues, or prolong the half-life of various drugs.

Leading Public Companies Associated with the Nanotechnology in Medicine Theme

Some of the leading public companies associated with the nanotechnology in medicine theme are Amgen, Bausch Health Companies, Biogen, Celgene, Eisai, F. Hoffmann-La Roche, Gilead Sciences, Ipsen, Jazz Pharmaceuticals, Lantheus Holdings, Merck, and Novo Nordisk.

Leading Private Companies Associated with the Nanotechnology in Medicine Theme

The leading private companies associated with the nanotechnology in medicine theme are AlfaSigma, Dompe Farmaceutici, GE Healthcare, Horizon Pharmaceuticals, and Janssen Pharmaceuticals.

For more insights on the nanotechnology in medicine theme, download a free report sample

Key Highlights

This report focuses on nanotechnology and nanomedicines that are currently approved by the FDA.

Reasons to Buy

  • GlobalData’s thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. It has a proven track record of identifying the important themes early, enabling companies to make the right investments ahead of the competition, and secure that all-important competitive advantage.
  • Develop and design your corporate strategies through an in-house expert analysis of nanomedicine by understanding the primary ways in which this theme is impacting the medical devices industry.
  • Stay up to date on the industry’s major players and where they sit in the value chain.
  • Identify emerging industry trends to gain a competitive advantage.

Bausch & Lomb
Pacira Pharma
Ipsen Biopharm
Jazz Pharma
GE Healthcare
F. Hoffman-La Roche

Table of Contents

Executive Summary


Technology/Thematic Briefing


Industry Analysis

Value Chain


Sector Scorecards


Further Reading

Our Thematic Research Methodology

About GlobalData

Contact Us

Frequently asked questions

Nanotechnology in Medicine – Thematic Research thematic reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Nanotechnology in Medicine – Thematic Research was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Nanotechnology in Medicine – Thematic Research in real time.

  • Access a live Nanotechnology in Medicine – Thematic Research dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.